Single Injection Appears to Prevent Virtually All Allergic Reactions

Single Injection Appears to Prevent Virtually All Allergic Reactions

We could be nearing a cure for those nasty spring allergies — and even allergic reactions altogether. A decades-old asthma medication called omalizumab, which is sold as Xolair, has shown that it can successfully treat seasonal allergies in preliminary clinical trials. Administered as a single injection, it represents a type of treatment using lab-made proteins known as monoclonal antibodies, which can cut off your body's allergic response at it…